Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer-Reference-Cited by-同舟云学术

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Published:2012-05-03 Issue:18 Volume:366 Page:1674-1685
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Mallick Ujjal,Harmer Clive,Yap Beng,Wadsley Jonathan,Clarke Susan,Moss Laura,Nicol Alice,Clark Penelope M.,Farnell Kate,McCready Ralph,Smellie James,Franklyn Jayne A.,John Rhys,Nutting Christopher M.,Newbold Kate,Lemon Catherine,Gerrard Georgina,Abdel-Hamid Abdel,Hardman John,Macias Elena,Roques Tom,Whitaker Stephen,Vijayan Rengarajan,Alvarez Pablo,Beare Sandy,Forsyth Sharon,Kadalayil Latha,Hackshaw Allan

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1109589

Cited by 476 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer;Clinical Nuclear Medicine;2024-01-19

2. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect;Frontiers in Endocrinology;2024-01-17

3. Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis;Endocrine Practice;2024-01

4. Focus on Thyroid Cancer in Elderly Patients;Endocrines;2023-12-05

5. Current practice in intermediate risk differentiated thyroid cancer – a review;Reviews in Endocrine and Metabolic Disorders;2023-11-23